tradingkey.logo
tradingkey.logo
Suchen

Artivion Inc

AORT
Zur Watchlist hinzufügen
23.970USD
+0.420+1.78%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
1.16BMarktkapitalisierung
93.41KGV TTM

mehr Informationen über Artivion Inc Unternehmen

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc Informationen

BörsenkürzelAORT
Name des UnternehmensArtivion Inc
IPO-datumFeb 12, 1993
CEOMackin (James Patrick)
Anzahl der mitarbeiter1600
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 12
Addresse1655 Roberts Boulevard N W
StadtKENNESAW
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl30144
Telefon17704193355
Websitehttps://artivion.com/
BörsenkürzelAORT
IPO-datumFeb 12, 1993
CEOMackin (James Patrick)

Führungskräfte von Artivion Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
76.22K
+9.94%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
61.37K
+12.34%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
60.26K
+44.40%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Artivion Inc?

Die fünf größten Anteilseigner von Artivion Inc sind: Mr. John E. Davis

Wie viele Institutionen halten Anteile an Artivion Inc (AORT)?

Mit Stand vom 2026Q1 halten 449 Institutionen Anteile an Artivion Inc, mit einem Gesamtmarktwert von etwa 45.29M, was 93.40% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 501666.00 gestiegen.

Was ist die größte Einnahmequelle von Artivion Inc?

Am 2026Q1 erzielte das Geschäft mit Aortic stent grafts für Artivion Inc den höchsten Umsatz in Höhe von 159.37M, was 36.11% des Gesamtumsatzes entspricht.